Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN-045).
HIV
contraception
couples
decision-making
multipurpose prevention technologies
pregnancy
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
06
04
2022
accepted:
21
09
2022
entrez:
18
10
2022
pubmed:
19
10
2022
medline:
20
10
2022
Statut:
ppublish
Résumé
Young women in sub-Saharan Africa account for two-thirds of all new HIV infections and face high rates of unintended pregnancy. Multipurpose prevention technologies (MPTs) are promising products under development that are designed to simultaneously prevent HIV and unintended pregnancy. Since MPTs will be used in the context of sexual relationships, ensuring acceptability and use requires understanding the role of male partners in MPT use decision-making. This paper draws on qualitative data from 39 couples enrolled in the Microbicide Trials Network (MTN) 045 study, conducted in 2019-2020. Partners completed a discrete choice experiment (DCE), first separately and then jointly, to measure preferences for future MPT attributes and then completed a qualitative interview. We also draw on quantitative data from interviewer observation about who dominated the decision-making process during the joint DCE. Content analysis was used to examine (1) how couples made decisions on existing non-MPT HIV and pregnancy prevention products; (2) how couples made decisions on future ideal-MPT product during the DCE; and (3) how these decision-making processes varied by decision-making dominance (10 male, 10 female and 19 equal) and interview type (19 joint and 20 separate). Existing non-MPT product decisions focused on trust between partners and product attributes, while future ideal-MPT product decisions exclusively focused on product attributes. Across existing and future products, preferences for product attributes varied by gender. Male partners were most concerned with limiting side effects impacting sexual pleasure, female partners were most concerned with limiting side effects causing physical symptoms and both were concerned with the return to fertility. Across all dominance and interview types, couples reported making decisions together and female partners were often able to negotiate with male partners for their preferred product or set of product attributes. Research activities in this study provided an opportunity for couples to openly present their product attribute preferences to their partner, learn about their partner's attribute preferences, negotiate for their ideal set of attributes and ultimately choose attributes that benefited the couple without disempowering the female partner. Future research should focus on the utility of couple-based decision-making aids or similar tools for facilitating joint MPT decision-making.
Identifiants
pubmed: 36254362
doi: 10.1002/jia2.26024
pmc: PMC9577116
doi:
Substances chimiques
Anti-Infective Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26024Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI068633
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068615
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI106707
Pays : United States
Informations de copyright
© 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
PLoS One. 2019 May 6;14(5):e0216208
pubmed: 31059524
Soc Sci Med. 2006 Mar;62(6):1369-80
pubmed: 16146666
PLoS One. 2012;7(7):e40661
pubmed: 22808227
J Int AIDS Soc. 2016 Nov 24;19(1):21224
pubmed: 27887669
J Sex Res. 2015;52(3):347-59
pubmed: 24670263
Reprod Health. 2014 Jan 02;11(1):1
pubmed: 24383405
PLoS One. 2018 Oct 31;13(10):e0204821
pubmed: 30379839
AIDS Behav. 2020 May;24(5):1432-1442
pubmed: 31667678
BJOG. 2014 Oct;121 Suppl 5:27-34
pubmed: 25335838
PLoS One. 2021 Jun 4;16(6):e0252745
pubmed: 34086806
Soc Sci Med. 2016 Oct;166:169-176
pubmed: 27566046
AIDS Behav. 2022 Jun 8;:
pubmed: 35674885
AIDS Care. 2015;27(1):31-7
pubmed: 25329436
Afr J Reprod Health. 2017 Jun;21(2):35-48
pubmed: 29624938
Infect Dis Obstet Gynecol. 2017;2017:1475813
pubmed: 28804240
Women Health. 2021 May-Jun;61(5):440-451
pubmed: 33941050
AIDS Behav. 2015 May;19(5):784-93
pubmed: 25416076
J Fam Psychol. 2011 Oct;25(5):759-69
pubmed: 21875192
Sex Transm Infect. 2012 Oct;88(6):436-43
pubmed: 22436198
Afr J Reprod Health. 2017 Mar;21(1):64-72
pubmed: 29595026
J Health Commun. 2012 Aug;17(7):802-19
pubmed: 22545820
BJOG. 2014 Oct;121 Suppl 5:9-11
pubmed: 25335833
J Soc Behav Health Sci. 2017;11:
pubmed: 29755646
Soc Sci Med. 2016 Mar;153:1-11
pubmed: 26859436
Contraception. 2007 May;75(5):383-9
pubmed: 17434021
Public Health Rep. 2010 Mar-Apr;125(2):208-17
pubmed: 20297747
Med Decis Making. 2018 Jan;38(1):120-133
pubmed: 28863752
AIDS Behav. 2020 Mar;24(3):802-811
pubmed: 31444713
PLoS One. 2018 Jun 14;13(6):e0198680
pubmed: 29902205
AIDS Behav. 2011 Jul;15(5):959-69
pubmed: 20844946
BMC Med. 2007 Oct 28;5:31
pubmed: 17963521
Reprod Health. 2017 Oct 5;14(1):125
pubmed: 28982364
Sex Reprod Health Matters. 2021 Dec;29(1):1927477
pubmed: 34224341
PLoS One. 2021 Feb 17;16(2):e0246717
pubmed: 33596216
Stud Fam Plann. 2021 Dec;52(4):397-413
pubmed: 34585384
PLoS One. 2013 Dec 30;8(12):e83193
pubmed: 24386160
Int J Environ Res Public Health. 2017 Mar 28;14(4):
pubmed: 28350334
J Nurs Scholarsh. 2008;40(1):12-9
pubmed: 18302586
BMJ Sex Reprod Health. 2021 Jul;47(3):166-172
pubmed: 32737137
BMC Public Health. 2016 Jan 16;16:44
pubmed: 26774918
BMC Pregnancy Childbirth. 2018 Jan 2;18(1):3
pubmed: 29291711
Int Perspect Sex Reprod Health. 2009 Jun;35(2):63-71
pubmed: 19620090
Afr J Reprod Health. 2013 Sep;17(3):79-90
pubmed: 24069770
Cochrane Database Syst Rev. 2014 Mar 30;(3):CD010915
pubmed: 24683022
Afr J Reprod Health. 2013 Sep;17(3):57-69
pubmed: 24069768
Cult Health Sex. 2014;16(7):792-805
pubmed: 24816215
AIDS Care. 2008 Jul;20(6):733-40
pubmed: 18576176
J Int AIDS Soc. 2018 Mar;21(3):e25094
pubmed: 29600595
AIDS Behav. 2018 Aug;22(8):2662-2673
pubmed: 29560570
J Behav Med. 2018 Aug;41(4):423-440
pubmed: 29468532
J Pediatr Adolesc Gynecol. 2020 Apr;33(2):144-148
pubmed: 31715367
Reprod Health. 2019 Jun 25;16(1):89
pubmed: 31238960
BMC Health Serv Res. 2011 Sep 17;11:220
pubmed: 21923927
Glob Public Health. 2022 Jul;17(7):1392-1405
pubmed: 33977862
Contraception. 2018 Mar;97(3):277-284
pubmed: 29055782
J Int AIDS Soc. 2020 Sep;23 Suppl 5:e25558
pubmed: 32869543
AIDS Care. 2016;28(2):228-33
pubmed: 26344386
Front Reprod Health. 2021 Jun;3:
pubmed: 34318291
BMC Public Health. 2021 Apr 14;21(1):720
pubmed: 33853559
J Int AIDS Soc. 2014 Mar 19;17:18585
pubmed: 24650763
Cult Health Sex. 2015;17 Suppl 2:S190-205
pubmed: 25953243
PLoS One. 2021 Jan 12;16(1):e0238662
pubmed: 33434205
J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1620-6
pubmed: 15577420
Infect Dis Obstet Gynecol. 2011;2011:691210
pubmed: 22144850